Cliff Asness's NAMS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 22,691 shares of NewAmsterdam Pharma Company N.V. (NAMS) worth $768,998, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in NAMS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 12,307 shares. Largest reduction occurred in Q4 2024, reducing 15,936 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's NewAmsterdam Pharma Company NV (NAMS) Holding Value Over Time
Track share changes against reported price movement
Quarterly NewAmsterdam Pharma Company NV (NAMS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +12,307 | Add 118.52% | 22,691 | $33.89 |
| Q1 2026 | +102 | Add 0.99% | 10,384 | $32.01 |
| Q4 2025 | +86 | Add 0.84% | 10,282 | $35.08 |
| Q3 2025 | +10,196 | New Buy | 10,196 | $28.44 |
| Q4 2024 | -15,936 | Sold Out | 0 | $0.00 |
| Q3 2024 | +15,936 | New Buy | 15,936 | $16.60 |
Cliff Asness's NewAmsterdam Pharma Company NV Investment FAQs
Cliff Asness first purchased NewAmsterdam Pharma Company N.V. (NAMS) in Q3 2024, acquiring 15,936 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held NewAmsterdam Pharma Company N.V. (NAMS) for 6 quarters since Q3 2024.
Cliff Asness's largest addition to NewAmsterdam Pharma Company N.V. (NAMS) was in Q3 2024, adding 15,936 shares worth $264,538.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 22,691 shares of NewAmsterdam Pharma Company N.V. (NAMS), valued at approximately $768,998.
As of the Q2 2026 filing, NewAmsterdam Pharma Company N.V. (NAMS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in NewAmsterdam Pharma Company N.V. (NAMS) was 22,691 shares, as reported at the end of Q2 2026.